The University of Michigan’s C.S. Mott Children’s Hospital is the largest, most experienced pediatric marrow transplant program in the state of Michigan, with recognized expertise in both established transplant techniques and innovative research initiatives.
Patients at Mott Children’s Hospital have access to the latest therapies and advanced procedures. Our physicians are leaders in the treatment and research of bone marrow transplants for children who have cancer, such as leukemia and lymphomas as well as diseases of the immune system, hemoglobin disorders, other bone marrow diseases and some metabolic diseases.
Blood and marrow transplant can be an effective treatment option for a number of blood disorders and cancers, including:
- Bone marrow failure syndromes
- Lymphoproliferative diseases
- Neutrophil disorders
- Wilm’s tumor
- Brain tumors
- Sickle cell disease
- Inborn errors of metabolism
Physicians and nurses dedicated specifically to the care of children undergoing BMT treatment are on site and available around the clock. Each member of our team is committed to working closely with children and their families to help them fully understand their care plan and the BMT treatment process.
Our success rates and donor match rates meet and, in many cases, exceed the national averages.
C.S. Mott Children’s Hospital is proud to be:
- A member of the National Marrow Donor Program.
- An active participant in the Children’s Oncology Group, whose mission is to cure and prevent childhood cancer through scientific discovery and compassionate care.
- Ranked among the nation’s top pediatric cancer programs by U.S. News & World Report
For adult patients:
Visit our Adult Blood and Marrow Transplant online.